Date>> <<First Name>> <<Last Name>> << Address line 1>> << Address line
Teva Anagrelide 0.5mg Capsule
Dissolution Test Failure Prompts Recall of Anagrelide Capsules - MPR
Anagrelide | Uses, Brand Names, Mechanism Of Action
Foglio illustrativo: Informazioni per il paziente Anagrelide Teva 0,5 mg capsule rigide anagrelide Medicinale equivalente Legga
Teva 00172524060 - McKesson Medical-Surgical
Teva recalls one lot of thrombocythemia med anagrelide in the U.S.
ANAGRELIDE HCL 1MG - RX Products
Anagrelide Teva 0.5mg cps.dur.100
Torrent Pharmaceuticals Recall Anagrelide Capsules over drug's Dissolution test Failure • Drugwatcher.org
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
These highlights do not include all the information needed to use ANAGRELIDE CAPSULES safely and effectively. See full prescribing information for ANAGRELIDE CAPSULES. ANAGRELIDE capsules, for oral useInitial U.S. Approval: 1997
Teva Recalls One Lot of Anagrelide Capsules, USP 0.5 mg Due to Dissolution Test Failure | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Anagrelide Hcl Generic Agrylin 0.5 Mg Caps 100 By Teva Pharma
Torrent Pharmaceuticals Recall Anagrelide Capsules over drug's Dissolution test Failure • Drugwatcher.org
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules, USP 0.5 mg Due to Dissolution Test Failure | FDA
Agrylin/anagrelide on Twitter: "Anagrelide、Agrylin、Xagrid https://t.co/r8xSuKKcke" / Twitter
Logo 5241 0.5 mg Pill Gray White Capsule-shape - Pill Identifier
Logo 5240 1 mg Pill White Capsule-shape - Pill Identifier
Anagrelide Teva 0,5 mg, harde capsules
FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes
FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes
